硕士生导师

首页  师资队伍  博导硕导  硕士生导师

陈广通

作者:金飞     日期:2023-11-02   点击数:2615  

师资介绍

陈广通,男,汉族,19812月生,博士,教授,硕士生导师。入选江苏省333高层次人才计划和江苏省“企业创新岗”特聘专家(科技副总)。



教育经历:

1999.09-2003.07沈阳药科大学,中药学,学士

2003.09-2008.07沈阳药科大学,天然药物化学,博士



工作经历:

2008.08-至今 南通大学,药学院,教授



研究方向:

中药和天然药物药效物质基础及活性成分生物转化研究



社会学术兼职:

南通市药学会中药专业委员会委员



基金项目:

1.南通市科技计划项目,MS12022026,新冠病毒肺炎恢复期肺脾气虚证治疗处方中三萜类有效组分的发现及其作用机制研究,2022/06-2024/0720万元,在研,主持。

2.南通市科技计划项目,JC2018122,基于TGF-β1/SmadMAPK信号通路的羽扇豆烷型三萜及其治疗肾脏纤维作用研究,2018/06-2020/073万元,结题,主持。

3.南通市科技计划项目,MS12015044,达玛烷型三萜的生物转化及抗肝纤维化构效关系研究,2015/06-2017/073万元,结题,主持。

4.南通市科技计划项目,AS2011019,牡荆子抗哮喘药效物质基础及体内药代动力学研究,2011/06-2013/073万元,结题,主持。

5.国家自然科学基金青年项目,81102327,达玛烷型三萜类成分生物转化及构效关系的研究,2012/01-2014/1221万元,结题,主持。

6.江苏省教育厅面上项目,10KJB350003,原人参二醇的微生物转化及抗肿瘤作用研究,2010/05-2012/045万元,结题,主持。



科研成果:

主要从事中药和天然药物药效物质基础及其活性成分的生物转化研究工作。近5年侧重于中药活性成分的发现、制备工艺和开发利用工作;及天然活性成分的生物酶催化研究,尤其是对三萜类活性成分的结构修饰和生物活性有较深入的研究,目前已发现多个新颖骨架类化合物,主要研究成果已发表SCI论文30多篇,主要发表在Organic Letters, Medicinal Research ReviewsPhytotherapy ResearchJournal of Natural ProductsPhytochemistry等天然产物主流期刊上获授权发明专利30多项,转让专利10多项。



成果奖励:

1、南通市科学技术进步奖,达玛烷型三萜的生物转化及抗肝纤维化构效关系研究,三等奖

2、南通大学优秀教育工作者



代表性论文:

1.Yanni Wu, Youjia Lu, Ying Yi, Andong Wang, Wenli Wang, Min Yang, Boyi Fan,Guangtong Chen*. Biotransformation of asiatic acid byCunninghamella echinulata andCircinella muscae to discover antineuroinflammatory derivatives.Natural Product Research2023, 37(16): 2712-2717.

2.Yan-Ni Wu, Dan Su, Jia Yang, Ying Yi, An-Dong Wang, Min Yang, Jian-Lin Li, Bo-Yi Fan, Guang-Tong Chen*, Wen-Li Wang, Bai Ling. Biotransformation of ursonic acid byAspergillus ochraceus and Aspergillus oryzae to discover anti-neuroinflammatory derivatives.Molecules2023, 28: 7943.

3.Lu, Youjia; Tang, Yifei; Wu, Yanni; Zhang, Xueying; Yi, Ying; Wang, Wenli; Wang, Andong; Yang, Min; Fan, Boyi;Chen, Guangtong*. Microbial transformation of betulonic acid byCircinella muscaeCGMCC 3.2695 and anti-neuroinflammatory activity of the products.Phytochemistry2022, 204: 113431.

4. Chu, CJ; Song, KN; Zhang, YZ; Yang, M; Fan, BY; Huang, HL; Chen, GT*. Biotransformation of ursolic acid byCircinella muscae and their anti-neuroinflammatory activities of metabolites.Natural Product Research2022, 36(11): 2777-2782.

5.K-N Song, Y-J Lu, C-J Chu, Y-N Wu, H-L Huang, B-Y Fan,G-T Chen*. Biotransformation of betulonic acid by the fungusRhizopus arrhizus CGMCC 3.868 and antineuroinflammatory activity of the biotransformation products.Journal of natural products2021, 84: 2664-2674.

6. C Chen, K-N Song, Y-Z Zhang, C-J Chu, B-Y Fan, Y Song*, H-L Huang,G-T Chen*. Biotransformation of betulinic acid byCircinella muscaeandCunninghamella echinulatato discover anti-inflammatory derivatives.Phytochemistry2021, 182: 112608.

7. C Chen, Y-H Ni, B-C Jiang, B-H Xu, B-Y Fan, H-L Huang,G-T Chen*. Anti-aging derivatives of cycloastragenol produced by biotransformation.Natural Product Research2021, 35(16): 2685-2690.

8.J-L Li, B-C Jiang, C Chen, B-Y Fan, H-L Huang,G-T Chen*. Biotransformation of betulin byMucor subtilissimus to discover anti-inflammatory derivatives.Phytochemistry2019,166: 112076.

9.B-Y Fan, Y Lu, M Yang, J-L Li*,G-T Chen*. Evolvulins I and II, resin glycosides with a trihydroxy aglycone unit fromEvolvulus alsinoides.Organic Letters2019, 21(16): 6548-6551.

10.B-Y Fan, H Ye, Y Lu, M Yang, Q Zhu,G-T Chen*, J-L-Li*. Glycosidic acids with unusual aglycone units fromConvolvulus arvensis.Journal of natural products2019, 82(6): 1593-1598.

11.B-Y Fan, B-C Jiang, S-S Yan, B-H Xu, H-L Huang,G-T Chen*. Anti-inflammatory 18β-glycyrrhetinin acid derivatives produced by biocatalysis.Planta Medica2019, 85(1): 56-61.

12S-S Yan,H-J Lin,H-L Huang,M Yang,B-H Xu,G-T Chen*.Microbial hydroxylation and glycosidation of oleanolic acid by Circinella muscae and their anti-inflammatory activities.Natural Product Research2019, 33(13): 1849-1855.

13.J-L Li,P-Y Ding,B-C Jiang,M Yang,J Ren,Y Song,G-T Chen*.Biotransformation of 20(R)-panaxatriol by the fungusAspergillus flavusLink AS 3.3950.Natural Product Research2019,33(10): 1393-1398.

14.H-J Lin, B-C Jiang, C Chen, Y Song, M Yang, H-L Huang,G-T Chen*.Microbial transformation of the anti-aging agent cycloastragenol byMucor racemosus.Natural Product Research2019, 33(21): 3103-3108.

15. B-Y Fan, Y Lu, H Yin, Y He, J-L Li*, G-T Chen*.Arvensic acids A-D, novel heptasaccharide glycosidic acids as the alkaline hydrolysis products of crude resin glycosides fromConvolvulus arvensis.Fitoterapia2018, 131: 209-214.

16.Y-Q Gu, P-Y Ding, Z-P Liang, Y Song, Y-H Liu,G-T Chen*, J-L Li*. Activated production of silent metabolites from marine-derived fungusPenicillium citrinum.Fitoterapia2018, 127: 207-211.

17.B Yan,Z-H Chen,X-G Zhai,G-BYin,Y-F Ai,G-T Chen*.Microbial carbonylation and hydroxylation of 20(R)-panaxadiol byAspergillus niger.Natural Product Research2018,32(7):782-787.

18.Y Song, S-S Yan, H-J Lin, J-L Li, X-G Zhai, J Ren,G-T Chen*. Biotransformation of 20(R)-panaxadiol by whole cells of filamentous fungusAbsidia coerulea AS 3.3382.Journal of Asian Natural Products Research2018, 20(8): 719-726.

19. G-T Chen, Y Lu, M Yang, J-L Li, B-Y Fan. Medicinal uses, pharmacology, and phytochemistry ofConvolvulacee plants with central nervous system efficacies: A systematic review.Phytotherapy Research2018, 32(5): 823-864.

20. Y Song, J Li, S-S Yan, H-J Lin, J-L Li, J-J Wu, X-G Zhai,G-T Chen*. Biotransformation of 20(R)-panaxatriol byAspergillus nigerAS 3.739.Phytochemistry Letters2017, 19: 89-93.


发明专利:

1专利名称:具有特殊七元环结构的三萜在制备预防和治疗神经损伤药物中的应用

专利号:ZL 202010420373.X

2专利名称:白桦醇及其衍生物在具有抗肝纤维化作用药物中的应用

专利号:ZL 201910201987.6

3专利名称:白桦醇衍生物及其制备方法与应用

专利号:ZL 201910201971.5

4专利名称:一种白桦脂酸衍生物及其制备方法与应用

专利号:ZL 202010960219.1

5专利名称:白桦脂酸衍生物在制备抗肿瘤药物中的应用

专利号:ZL 202010959717.4

6专利名称:白桦脂酸衍生物在制备抗肾病变药物中的应用

专利号:ZL 202010959695.1

7专利名称:白桦脂酸衍生物在制备抗肝病变药物中的应用

专利号:ZL 202010959718.9

8专利名称:白桦脂酸衍生物在制备治疗神经损伤疾病的药物中的应用

专利号:ZL 202010960220.4

9专利名称:熊果酸衍生物在制备预防或治疗心血管疾病药物中的应用

专利号:ZL 202110416787.X

10专利名称:熊果酸衍生物在制备抗肿瘤药物中的应用

专利号:ZL 202110416790.1

11专利名称:熊果酸衍生物在制备抗肾病变药物中的应用

专利号:ZL 202110416770.4

12专利名称:一种熊果酸衍生物及其制备方法与应用

专利号:ZL 202110416767.2

13专利名称:熊果酸衍生物在制备治疗神经系统疾病药物中的应用

专利号:ZL 202110416785.0

14专利名称:白桦醇衍生物在制备修复神经损伤药物中的新用途

专利号:ZL 202010421471.5

15专利名称:一种白桦脂酮酸衍生物及其制备方法与应用

专利号:ZL 202211073297.5